Orally active αvβ3 integrin inhibitor MK0429 reduces melanoma metastasis

By        

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2737-2745

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of αvβ3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases

By Nemeth Jeffrey   Cher Michael   Zhou Zhao   Mullins Chadwick   Bhagat Sunita   Trikha Mohit  

Clinical and Experimental Metastasis, Vol. 20, Iss. 5, 2003-09 ,pp. : 413-420

Springer Publishing Company

Access to resources Recommend Favorite

Integrin αvβ3 Signaling in Tumor-Induced Bone Disease

By Kwakwa Kristin A.   Sterling Julie A.  

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 84-84

MDPI

Access to resources Recommend Favorite

HOXD3-overexpression increases integrin αvβ3 expression and deprives E-cadherin while it enhances cell motility in A549 cells

By Ohta Hironori   Hamada Jun-ichi   Tada Mitsuhiro   Aoyama Tetsuya   Furuuchi Keiji   Takahashi Yoko   Totsuka Yasunori   Moriuchi Tetsuya  

Clinical and Experimental Metastasis, Vol. 23, Iss. 7-8, 2006-12 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis

By Staflin Karin   Krueger Joseph   Hachmann Janna   Forsyth Jane   Lorger Mihaela   Steiniger Sebastian   Mee Jenny   Pop Cristina   Salvesen Guy   Janda Kim   Felding-Habermann Brunhilde  

Clinical and Experimental Metastasis, Vol. 27, Iss. 4, 2010-04 ,pp. : 217-231

Springer Publishing Company

Access to resources Recommend Favorite